Triple Negative Breast Cancer Foundation

TOUCH, The Black Breast Cancer Alliance and partners awarded Gilead Sciences grant to build Black TNBC Matters resource hub for Black people impacted by triple negative breast cancer

Retrieved on: 
Tuesday, June 27, 2023
Oncology, Health, Consumer, Women, Teens, General Health, Hispanic, Survival rate, TNBC, Darkness, Gilead Sciences, Corporate Affairs, Partnership, AACR, General counsel, Health equity, Nueva Vida, American Association for Cancer Research, Hope, Statistics, Research, Black, Doctor of Philosophy, Computer, Triple Negative Breast Cancer Foundation, SEO, Triple-negative breast cancer, Nueva, Patient, Mobile, Mortality, Recurrence, Death, Breast cancer, Birth control, Pharmaceutical industry, TOUCH

TOUCH, The Black Breast Cancer Alliance—in partnership with the Triple Negative Breast Cancer Foundation, the American Association for Cancer Research (AACR), and Nueva Vida—was awarded the first “Toward Health Equity for Black People Impacted by Triple Negative Breast Cancer Resource Hub” grant from Gilead Sciences for their project Black TNBC Matters.

Key Points: 
  • TOUCH, The Black Breast Cancer Alliance—in partnership with the Triple Negative Breast Cancer Foundation, the American Association for Cancer Research (AACR), and Nueva Vida—was awarded the first “Toward Health Equity for Black People Impacted by Triple Negative Breast Cancer Resource Hub” grant from Gilead Sciences for their project Black TNBC Matters.
  • “Black TNBC Matters will start—and be grounded throughout the process—in community,” says Ricki Fairley, CEO of TOUCH, The Black Breast Cancer Alliance.
  • “The first thing that someone newly diagnosed with triple negative breast cancer does after they leave their doctor’s office is to search ‘triple negative breast cancer’ online.
  • Black TNBC Matters aims to be that source—a living, breathing resource that evolves and grows based on the ever-changing landscape of Black TNBC.

Springfield Banking Veteran Rob Fulp Joins Great Southern Bank

Retrieved on: 
Wednesday, April 5, 2023
State, Great Southern Bank, Missouri State University, University college, Great Southern, University Foundation, Triple Negative Breast Cancer Foundation, Retirement, Breast cancer, Community Bank, Ozarks, Guaranty Bank

SPRINGFIELD, Mo., April 05, 2023 (GLOBE NEWSWIRE) -- Great Southern Bank today announced that it has hired Springfield banking veteran Rob Fulp.

Key Points: 
  • SPRINGFIELD, Mo., April 05, 2023 (GLOBE NEWSWIRE) -- Great Southern Bank today announced that it has hired Springfield banking veteran Rob Fulp.
  • Great Southern President and CEO Joe Turner said, “We are excited that Rob has joined the Great Southern team.
  • Great Southern, along with its strength and scope, made this a great fit for the next phase of my banking career.”
    Fulp’s banking career has spanned more than 40 years in the Springfield market.
  • With total assets of $5.7 billion, Great Southern offers a broad range of banking services to commercial and consumer customers.

Xeris Biopharma Appoints Ricki Fairley to Board of Directors

Retrieved on: 
Wednesday, March 29, 2023
Biotechnology, Pharmaceutical, Managed Care, General Health, Health, Diabetes, Medical Devices, Other Health, The Coca-Cola Company, Kellogg School of Management, Clinical trial, Black Enterprise, AMA Foundation Leadership Award, Woman, MBA, Multimedia, Research, Dartmouth College, Strategic planning, Marketing, Triple Negative Breast Cancer Foundation, Reckitt, Movement, Triple-negative breast cancer, American Cancer Society, Patient, Trustee, Creative, Chairperson, Johnson & Johnson, Nabisco, Northwestern University, BA, Breast cancer, Management, Black

Xeris Biopharma Holdings (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapeutic areas, appointed Ricki Fairley to its Board of Directors, increasing the size of the Board to nine members, on March 27, 2023.

Key Points: 
  • Xeris Biopharma Holdings (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapeutic areas, appointed Ricki Fairley to its Board of Directors, increasing the size of the Board to nine members, on March 27, 2023.
  • Ms. Fairley serves on the Board of Trustees for the Triple Negative Breast Cancer Foundation.
  • She is a board member for the Center for Healthcare Innovation and serves on the National Minority Quality Forum Scientific Advisory Board for Project Moonshot.
  • I look forward to bringing my patient advocate voice to the company’s passionate and committed pursuit of changing patients’ lives,” says Ricki Fairley.

St. Andrews Country Club Play for P.I.N.K. Events Raise $125,000 With More than 350 Club Members Participating in Multi-Sports Competitions

Retrieved on: 
Monday, March 28, 2022
Pinterest, Play, LinkedIn, Golf, The National Parks: America's Best Idea, Triple Negative Breast Cancer Foundation, Callaway Golf Company, LPGA, Strathcona County, Immunotherapy, Parent, Recreation, Genetics, PGA, Research, Arnold Palmer, Spouse, Top Ten, Club, Tennis, Breast, Clubhouse, Breast cancer, Grandparent, Foundation, YouTube, Sport, Breast Cancer Research Foundation, BRCA, Instagram, Estée Lauder, Immediate, Nightclub, Knowledge, Facebook

BOCA RATON, Fla., March 28, 2022 /PRNewswire-PRWeb/ -- From women's tennis and pickleball to women's and men's golf tournaments, more than 350 St. Andrews Country Club members took to the courts and fairways in its 2022 Play for P.I.N.K. events that raised more than $125,000 to support the Breast Cancer Research Foundation. According to St. Andrews Country Club members Serena Werber and Carin Boris who co-chaired the events, this is the 16th year that the Club has "turned play into serious support" for the Play for P.I.N.K. (Prevention, Immediate diagnosis, New technology, Knowledge) mission to speed advances in breast cancer detection, treatment, and survivorship.

Key Points: 
  • From women's tennis and pickleball to women's and men's golf tournaments, more than 350 St. Andrews Country Club members took to the courts and fairways in its 2022 Play for P.I.N.K.
  • According to St. Andrews Country Club members Serena Werber and Carin Boris who co-chaired the events, this is the 16th year that the Club has "turned play into serious support" for the Play for P.I.N.K.
  • organization, the co-chairs and committee for the St. Andrews Country Club's event spent several months planning the diverse sports initiative.
  • ( https://www.playforpink.org/ ) initiative supports thousands of volunteers nationwide, such as St. Andrews Country Club membership, as they raise funds for research through sporting and lifestyle events.

TOUCH, The Black Breast Cancer Alliance, and Breastcancer.org lead unprecedented When We Tri(al) movement to address breast cancer clinical trial disparities

Retrieved on: 
Tuesday, March 1, 2022
Triple Negative Breast Cancer Foundation, Triple-negative breast cancer, Movement, Somatosensory system, Death, Healthcare disparity in Massachusetts, Education, Daiichi Sankyo, Novartis, Industry, Survivor, Clinical trial, Breast cancer, Organization, Safety, Bristol Myers Squibb, Hope, Woman, Multimedia, Science, Leadership, Life, Hoffmann-La Roche, Patient, Health equity, TOUCH, Eisai, CEO, Research, Face, Mortality, AstraZeneca, Time, Birth control, Medical imaging, Pharmaceutical industry, Black, Pfizer, Genentech

Until more Black women are included in research, they will continue to face worse breast cancer outcomes.

Key Points: 
  • Until more Black women are included in research, they will continue to face worse breast cancer outcomes.
  • When We Tri(al), a movement dedicated to empowering and educating Black women on the importance of clinical trial participation, aims to change the devastating breast cancer mortality rates for Black women, who are 41% more likely to die from breast cancer than white women.
  • "We MUST advance the science for Black Breast Cancer," says Ricki Fairley, CEO of TOUCH, The Black Breast Cancer Alliance.
  • We believe that providing resources about breast cancer clinical trials with impactful messaging for Black women will lead to lifesaving opportunities and better representation in research.

Luvme Hair's Support in Breast Cancer Awareness Month

Retrieved on: 
Monday, November 1, 2021
Woman, Breast cancer, Cancer, Disease, Awareness, Organization, Hair, Risk, BCAM, Multimedia, Triple Negative Breast Cancer Foundation, Breast, Prevalence, Education, LBBC, Birth control

With the hope of getting more people to participate in raisingawareness for breast cancer and getting support fromsociety, the top human hair wig brand Luvme Hair steps up to raise awareness and gives funds to help breast cancer support organizations.

Key Points: 
  • With the hope of getting more people to participate in raisingawareness for breast cancer and getting support fromsociety, the top human hair wig brand Luvme Hair steps up to raise awareness and gives funds to help breast cancer support organizations.
  • Luvme Support -From October 15 to 17th, Luvme Hair launched a Luvme Support campaign on its social media channels.
  • Seeing your support for the fight against breast cancer makes me proud to support your brand.
  • After learning the situation, Luvme Hair pledged to donate $5,000 to LBBC for education and support of the breast cancer community and created breast cancer awareness brochures for its clients.

 Merck and Emmy-Nominated Actress Yvonne Orji Unveil Uncovering TNBC, Highlighting the Challenges Faced by Black Women Diagnosed with Triple-Negative Breast Cancer

Retrieved on: 
Tuesday, October 5, 2021
Oncology, Education, Entertainment, Health, Film & Motion Pictures, General Health, Other Education, MSD, Strathcona County, Infection, News, Patent, Animal, Coronavirus, Vaccine, Instagram, Diagnosis, Living Beyond Breast Cancer, RED, Breast, Annual report, Health, Security (finance), Merck & Co., Cancer, Multimedia, TNBC, MRK, Patient, Pregnancy, Population, U.S. Securities and Exchange Commission, Triple-negative breast cancer, LinkedIn, YouTube, Television, Triple Negative Breast Cancer Foundation, Twitter, Public health, CEO, Private Securities Litigation Reform Act, Face, Program, Woman, Life, PSI, HIV/AIDS, Disease, Medicine, NGO, COVID-19, Research, Uncovered (Steve Harley album), HBO, Health equity, Social marketing, Organization, HIV, NYSE, Population Services International, Breast cancer, SEC, Birth control, Entertainment, Pharmaceutical industry, Uncovering TNBC, Yvonne Orji, Merck, UNCOVERING TNBC, YVONNE ORJI, MERCK

Non-Hispanic Black women are approximately two times more likely to have TNBC than non-Hispanic white women, and compared to white women, Black women are more likely to die of the disease.

Key Points: 
  • Non-Hispanic Black women are approximately two times more likely to have TNBC than non-Hispanic white women, and compared to white women, Black women are more likely to die of the disease.
  • I know firsthand how important it is for Black women to take charge of their health and advocate for themselves.
  • The centerpiece of the Uncovering TNBC campaign is a three-episode web docuseries that highlights the challenges Black women with TNBC can face throughout their cancer journeys.
  • For Black women with TNBC, optimal care is about more than just treating cancer: Its about being understood and supported.

Susan G. Komen Welcomes Nine New Research and Patient Advocacy Leaders to Advisory Roles

Retrieved on: 
Wednesday, June 23, 2021
Research, Family, Philanthropy, Oncology, Consumer, Fund Raising, Foundation, Science, Women, Other Philanthropy, Other Science, Health, Cancer, Breast cancer, Health, Triple Negative Breast Cancer Foundation, Susan G. Komen for the Cure

Susan G. Komen , the worlds leading breast cancer organization, today announced the addition of six esteemed breast cancer researchers and three new patient advocates to important advisory roles.

Key Points: 
  • Susan G. Komen , the worlds leading breast cancer organization, today announced the addition of six esteemed breast cancer researchers and three new patient advocates to important advisory roles.
  • Chosen for their knowledge, leadership and contributions to breast cancer research, Komen Scholars provide scientific expertise and guidance to a variety of Komen programs, including leading Komens scientific peer review process.
  • Tomika serves as a consumer reviewer for the Department of Defenses Breast Cancer Research Program, serves on Komens Advocacy Advisory Taskforce, and was a co-founder of the Black Womens Cancer Collaborative, in addition to other advisory and leadership roles.
  • Susan G. Komen is the worlds leading nonprofit breast cancer organization, working to save lives and end breast cancer forever.

Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine

Retrieved on: 
Monday, November 23, 2020
Breast cancer, Triple-negative breast cancer, Medical specialties, Health, Cancer, Vaccine, Lactalbumin, Branches of biology, Triple Negative Breast Cancer Foundation

This vaccine technology was invented by a research team from Cleveland Clinic, led by Dr. Vincent Tuohy, the Mort and Iris November Distinguished Chair in Innovative Breast Cancer Research in the Department of Inflammation and Immunity at Cleveland Clinic's Lerner Research Institute.

Key Points: 
  • This vaccine technology was invented by a research team from Cleveland Clinic, led by Dr. Vincent Tuohy, the Mort and Iris November Distinguished Chair in Innovative Breast Cancer Research in the Department of Inflammation and Immunity at Cleveland Clinic's Lerner Research Institute.
  • Dr. Tuohy discovered that this protein is abnormally expressed again when a woman contracts breast cancer, especially Triple Negative Breast Cancer (TNBC), the most deadly form of this disease.
  • "If our data demonstrate results similar to the pre-clinical studies, this vaccine could have a significant impact on breast cancer, the most common malignancy in women.
  • The company's vaccine portfolio consists of a technology focused on the immunization against -Lactalbumin to prevent triple negative breast cancer (TNBC).

Susan G. Komen® Calls on Everyone to Take Action on Metastatic Breast Cancer

Retrieved on: 
Monday, October 12, 2020
Health, Philanthropy, Women, Oncology, Other Philanthropy, Other Science, Research, Fund Raising, Foundation, Consumer, Science, Breast cancer, Breast cancer awareness, Cancer, Metastatic breast cancer, Health, Susan G. Komen for the Cure, Triple Negative Breast Cancer Foundation

Susan G. Komen , the worlds leading breast cancer organization, today announced that in recognition of Metastatic Breast Cancer Awareness Day, all donations made online to the organization between Oct. 12-16 will go solely to support research focused on metastatic breast cancer (MBC).

Key Points: 
  • Susan G. Komen , the worlds leading breast cancer organization, today announced that in recognition of Metastatic Breast Cancer Awareness Day, all donations made online to the organization between Oct. 12-16 will go solely to support research focused on metastatic breast cancer (MBC).
  • Research is the only thing that will lead to more, and better, treatments for metastatic breast cancer, said Victoria Wolodzko, senior vice president of Mission at Susan G. Komen.
  • In addition to research and advocacy, Komen supports metastatic breast cancer patients throughout the year through patient-centered services.
  • Susan G. Komen is the worlds leading nonprofit breast cancer organization, working to save lives and end breast cancer forever.